Meeder Asset Management Inc Oncternal Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$1.7 - $3.28 $3,624 - $6,992	-2,132 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$2.43 - $3.23 $5,618 - $7,467	-2,312 Reduced 52.03%	2,132 $6,000
Q1 2020 May 15, 2020	SELL	$2.49 - $4.39 $498 - $877	-200 Reduced 4.31%	4,444 $12,000
Q3 2019 Oct 17, 2019	BUY	$3.87 - $6.13 $10,483 - $16,606	2,709 Added 140.0%	4,644 $23,000
Q2 2019 Aug 05, 2019	BUY	$4.86 - $9.24 $9,404 - $17,879	1,935 New	1,935 $13,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $63.3M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.